Healthcare -
Biotechnology - NASDAQ - US
$ 19.935
-0.722 %
$ 1.58 B
Market Cap
-4.61
P/E
VRDN - OTHER FINANCING ACTIVITIES
Other Financing Activities VRDN - Viridian Therapeutics, Inc.
85.6 M
LAST VALUE
124.66%
2 YEAR CAGR
103.34%
5 YEAR CAGR
301.83%
10 YEAR CAGR